N4BP2L2 and colorectal carcinoma: To further investigate the cross-talk between circN4BP2L2 and miR-664b-3p in CRC cell progression, CAFs-sEV/sh-N4BP2L2 was co-transfected with miR-664b-3p inhibitor or inhibitor NC in LoVo cells.